Cargando…

Analysis of BRCA1 and RAD51C Promoter Methylation in Italian Families at High-Risk of Breast and Ovarian Cancer

Previous studies on breast and ovarian carcinoma (BC and OC) revealed constitutional BRCA1 and RAD51C promoter hypermethylation as epigenetic alterations leading to tumor predisposition. Nevertheless, the impact of epimutations at these genes is still debated. One hundred and eight women affected by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabano, Silvia, Azzollini, Jacopo, Pesenti, Chiara, Lovati, Sara, Costanza, Jole, Fontana, Laura, Peissel, Bernard, Miozzo, Monica, Manoukian, Siranoush
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226593/ https://www.ncbi.nlm.nih.gov/pubmed/32276467 http://dx.doi.org/10.3390/cancers12040910

Ejemplares similares

Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies
por: Azzollini, Jacopo, et al.
Publicado: (2017)

Constitutive BRCA1 Promoter Hypermethylation Can Be a Predisposing Event in Isolated Early-Onset Breast Cancer
por: Azzollini, Jacopo, et al.
Publicado: (2019)

Co-occurrence of Mayer-Rokitansky-Küster-Hauser syndrome and ovarian cancer: A case report and review of the literature
por: Villa, Roberta, et al.
Publicado: (2019)

Increased access to TP53 analysis through breast cancer multi-gene panels: clinical considerations
por: Azzollini, Jacopo, et al.
Publicado: (2017)

Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinoma
por: Azzollini, Jacopo, et al.
Publicado: (2023)

A Dietary Intervention to Lower Serum Levels of IGF-I in BRCA Mutation Carriers
por: Pasanisi, Patrizia, et al.
Publicado: (2018)

Adherence to Mediterranean Diet and Metabolic Syndrome in BRCA Mutation Carriers
por: Bruno, Eleonora, et al.
Publicado: (2017)

BRCA1/2 Variants and Metabolic Factors: Results From a Cohort of Italian Female Carriers
por: Oliverio, Andreina, et al.
Publicado: (2020)

Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction
por: Subramanyam, Shyamal, et al.
Publicado: (2013)

Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1
por: Caleca, Laura, et al.
Publicado: (2014)

Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status
por: Cunningham, J. M., et al.
Publicado: (2014)

First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report
por: Ripamonti, Carla B, et al.
Publicado: (2013)

Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations
por: Colombo, Mara, et al.
Publicado: (2013)

Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model
por: Azzollini, Jacopo, et al.
Publicado: (2022)

Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy
por: Figlioli, Gisella, et al.
Publicado: (2021)

Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations
por: Gonzalez, R, et al.
Publicado: (1999)

Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis
por: Tomasello, G., et al.
Publicado: (2022)

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families
por: Osher, D J, et al.
Publicado: (2012)

Non-Recombinogenic Functions of Rad51, BRCA2, and Rad52 in DNA Damage Tolerance
por: Prado, Félix
Publicado: (2021)

The Genetic Landscape of Human Glioblastoma and Matched Primary Cancer Stem Cells Reveals Intratumour Similarity and Intertumour Heterogeneity
por: Pesenti, Chiara, et al.
Publicado: (2019)

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
por: Łukomska, Alicja, et al.
Publicado: (2021)

Purified human BRCA2 stimulates RAD51-mediated recombination
por: Jensen, Ryan B., et al.
Publicado: (2010)

Genetic instability in the RAD51 and BRCA1 regions in breast cancer
por: Nowacka-Zawisza, Maria, et al.
Publicado: (2006)

Structural basis for stabilisation of the RAD51 nucleoprotein filament by BRCA2
por: Appleby, Robert, et al.
Publicado: (2023)

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D
por: Yang, Xin, et al.
Publicado: (2020)

LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer
por: Dey, Goutam, et al.
Publicado: (2023)

A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell death
por: Scott, Duncan E., et al.
Publicado: (2021)

Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases
por: Catucci, Irene, et al.
Publicado: (2012)

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor
por: Ogrodniczak, Alicja, et al.
Publicado: (2022)

BRCA2 Acts as RAD51 Loader to Facilitate Telomere Replication and Capping
por: Badie, Sophie, et al.
Publicado: (2010)

Conformational flexibility and oligomerization of BRCA2 regions induced by RAD51 interaction
por: Sidhu, Arshdeep, et al.
Publicado: (2020)

miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
por: Crippa, Elisabetta, et al.
Publicado: (2014)

Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer
por: Hansmann, Tamara, et al.
Publicado: (2012)

Yeast Rad52 is a homodecamer and possesses BRCA2-like bipartite Rad51 binding modes
por: Deveryshetty, Jaigeeth, et al.
Publicado: (2023)

The Impact of Mediterranean Dietary Intervention on Metabolic and Hormonal Parameters According to BRCA1/2 Variant Type
por: Oliverio, Andreina, et al.
Publicado: (2022)

Roles of XRCC2, RAD51B and RAD51D in RAD51-Independent SSA Recombination
por: Serra, Heïdi, et al.
Publicado: (2013)

Noncanonical Roles of RAD51
por: Thomas, Mélissa, et al.
Publicado: (2023)

Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor
por: Greenhough, Luke A., et al.
Publicado: (2023)

The Epistatic Relationship between BRCA2 and the Other RAD51 Mediators in Homologous Recombination
por: Qing, Yong, et al.
Publicado: (2011)

The Carboxyl Terminus of Brca2 Links the Disassembly of Rad51 Complexes to Mitotic Entry
por: Ayoub, Nabieh, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ca0dcod95uhtonhljpqacchvse